Centre hospitalier affilié universitaire de Quebec - Hopital l'Enfant-Jesus
Québec, Quebec, G1J 1Z4, Canada
NCT Number: NCT01469871
The purpose of this study is to determine if one of the new types of dressings (MEPORE PRO and/or MEPILEX BORDER ) will reduce the blister rate compared to the currently used HYPAFIX.
Looking for future studies?
Notify Me45 year and older
All sexes
Interventional
Phase 4
Québec, Quebec, G1J 1Z4, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The wound will be dressed using the Hypafix Transparent dressing after hip surgery.
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
The actual costs related to a tape blister will be calculated by adding the costs of additional dressings, the costs associated with an extended hospital stay and the additional costs associated with the use of external resources.
Hopital de l'Enfant-Jesus
Other
Reduction of Tape Blisters After Hip Surgery. A Prospective Evaluation of Three Types of Dressings.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00001505
Blister, Dermatologic Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06834243
Agnosia, Hip Surgery
Tekirdağ, Turkey (Türkiye)
View Trial DetailsNCT06166602
Hip Surgery, Neurologic Manifestations
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07427082
Femoral Fractures, Femoral Neck Fractures
Gaziantep, Turkey (Türkiye)
View Trial Details